Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Palatin Technologies, Inc. Common Stock
(NY:
PTN
)
22.80
+0.81 (+3.68%)
Streaming Delayed Price
Updated: 2:44 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Palatin Technologies, Inc. Common Stock
< Previous
1
2
3
4
5
Next >
3 Penny Stocks to Buy to Unlock 2,500% Upside Potential
↗
January 11, 2024
These penny stocks have triple-digit upside as 2024 brings easing monetary policy and economic normalization.
Via
InvestorPlace
Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.
January 03, 2024
From
Cosette Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
December 27, 2023
Via
Benzinga
Analysts Say 3 Stocks Have a Combined Upside of 3000%
↗
December 23, 2023
These high-risk, high-reward bets could be at an inflection point before their growth takes off next year.
Via
InvestorPlace
Recap: Palatin Techs Q1 Earnings
↗
November 14, 2023
Via
Benzinga
Palatin Techs's Earnings Outlook
↗
November 13, 2023
Via
Benzinga
Earnings Outlook For Palatin Techs
↗
September 27, 2023
Via
Benzinga
Recap: Palatin Techs Q3 Earnings
↗
May 16, 2023
Via
Benzinga
Palatin Techs Earnings Preview
↗
May 15, 2023
Via
Benzinga
Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket
↗
December 15, 2023
Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increase in third-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
December 15, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
December 15, 2023
It's time to dive into the biggest pre-market stock movers for Friday morning as we check out the winners and losers today!
Via
InvestorPlace
Palatin Technologies Earnings Perspective: Return On Capital Employed
↗
February 16, 2023
Via
Benzinga
Earnings Outlook For Palatin Technologies
↗
February 14, 2023
Via
Benzinga
Palatin Technologies's Return On Capital Employed Insights
↗
December 23, 2022
Via
Benzinga
Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders
October 19, 2023
EQNX::TICKER_START (NYSE:PTN),(NASDAQ:RYTM),(NASDAQ:VKTX),(NASDAQ:GPCR),(NYSE:NVO) EQNX::TICKER_END
Via
FinancialNewsMedia
Earnings Scheduled For September 28, 2023
↗
September 28, 2023
Companies Reporting Before The Bell • CarMax (NYSE:KMX) is projected to report quarterly earnings at $0.78 per share on revenue of $7.03 billion.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
August 07, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
September 19, 2023
During Tuesday's session, 275 companies made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
July 21, 2023
On Friday, 54 companies hit new 52-week lows.
Via
Benzinga
Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year’s End
August 09, 2023
EQNX::TICKER_START (NYSE:PTN),(NASDAQ:CRDF),(NASDAQ:BDRX),(NASDAQ:DRUG),(NYSE:LLY) EQNX::TICKER_END
Via
FinancialNewsMedia
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
July 06, 2023
It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday!
Via
InvestorPlace
Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
August 07, 2023
Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
December 21, 2022
On Wednesday, 152 stocks made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
December 23, 2022
OnFriday, 143 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
December 22, 2022
Thursday's session saw 329 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
December 20, 2022
On Tuesday, 298 companies achieved new lows for the year.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
November 29, 2022
On Tuesday, 89 companies set new 52-week lows.
Via
Benzinga
Looking Into Palatin Technologies's Return On Capital Employed
↗
September 23, 2022
Palatin Technologies (AMEX:PTN) brought in sales totaling $770 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 67.3%, resulting in a loss of $12.77 million.
Via
Benzinga
Earnings Scheduled For November 14, 2022
↗
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today